TCM
AMGN icon

Tuttle Capital Management’s Amgen AMGN Stock Holding History

Tuttle Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,721
Closed -$626K – 243
2020
Q4 		$626K Buy
2,721
+846
+45% +$195K 0.48% 53
2020
Q3 		$477K Buy
+1,875
New +$465K 0.33% 73
2019
Q4 		– Sell
-10,526
Closed -$2.2M – 97
2019
Q3 		$2.2M Buy
+10,526
New +$2.02M 0.58% 51
2018
Q4 		– Sell
-11,100
Closed -$2.3M – 82
2018
Q3 		$2.3M Buy
+11,100
New +$2.19M 0.44% 55

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tuttle Capital Management's AMGN Position: Q1 2021 in Review

Tuttle Capital Management sold out of Amgen (AMGN) in Q1 2021, closing a stake of 2,721 shares — an estimated $626K sold.

Tuttle Capital Management first reported a position in AMGN in Q3 2018 and held it in 4 quarters. The position peaked at $2.3M in Q3 2018. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Tuttle Capital Management reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Tuttle Capital Management sold 2,721 Amgen shares in Q1 2021, an estimated $626K.
  • Tuttle Capital Management first reported a position in Amgen in Q3 2018 and held it in 4 quarters.
  • Tuttle Capital Management's Amgen position peaked at $2.3M in Q3 2018.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Tuttle Capital Management's 13F filing for Q1 2021, filed 27 Apr 2021.